Adjuvant Tebentafusp in High Risk Ocular Melanoma

Conditions: Uveal Melanoma Interventions: Drug: Tebentafusp Sponsors: European Organisation for Research and Treatment of Cancer - EORTC; Northwell Health Cancer Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials